Chang-Gong Liu

Molecular Biology · 2004–2010

A researcher in the Science corpus: 22 papers; trusts 5 researchers and is trusted by 13 researchers here, as inferred from the citation graph.

Subfields

• Molecular Biology — 360 citations into it; #5,017 of 17,773 by trust here, #396 by citations
• Cancer Research — 339 citations into it; #226 of 1,780 by trust here, #30 by citations

Whom Chang-Gong Liu trusts overall

Their strongest outbound trust, strongest first, inferred from their citations.

1. George A. Calin
2. V. Ambros

Who trusts Chang-Gong Liu overall

1. George A. Calin
2. Carlo Maria Croce
3. Marilena V. Iorio
4. K. Reddy
5. Scott M. Hammond
6. S. Shenouda
7. M. Ferracin
8. O. Kent
9. J. Thomson
10. Leigh-Ann MacFarlane

Papers from Chang-Gong Liu's perspective

Ordered by how strongly the researchers Chang-Gong Liu trusts endorse each paper. Same corpus, a different order for every researcher.

1. A combined computational-experimental approach predicts human microRNA targets. (Genes & Development)
2. MicroRNA maturation: stepwise processing and subcellular localization (EMBO Journal)
3. Prediction of mammalian microRNA targets. (Cell)
4. A microRNA polycistron as a potential human oncogene (Nature)
5. A mammalian microRNA expression atlas based on small RNA library sequencing. (Cell)
6. A Drosophila fragile X protein interacts with components of RNAi and ribosomal proteins. (Genes & Development)
7. Serum response factor regulates a muscle-specific microRNA that targets Hand2 during cardiogenesis (Nature)
8. Expression profiling reveals off-target gene regulation by RNAi
9. MicroRNA-Directed Cleavage of HOXB8 mRNA (Science)
10. MicroRNA targeting specificity in mammals: determinants beyond seed pairing. (Molecules and Cells)

Their papers

• miR-15 and miR-16 induce apoptosis by targeting BCL2. (2005) — 3,834 citations
• MicroRNA gene expression deregulation in human breast cancer. (2005) — 4,255 citations
• A microRNA expression signature of human solid tumors defines cancer gene targets (2006) — 6,046 citations
• An oligonucleotide microchip for genome-wide microRNA profiling in human and mouse tissues. (2004) — 972 citations
• Unique microRNA molecular profiles in lung cancer diagnosis and prognosis. (2006) — 3,193 citations
• MicroRNA profiling reveals distinct signatures in B cell chronic lymphocytic leukemias. (2004) — 1,351 citations
• Ultraconserved regions encoding ncRNAs are altered in human leukemias and carcinomas. (2007) — 744 citations
• MicroRNAs 221 and 222 inhibit normal erythropoiesis and erythroleukemic cell growth via kit receptor down-modulation. (2005) — 795 citations
• A MicroRNA Signature of Hypoxia (2006) — 1,078 citations
• MicroRNA signatures in human ovarian cancer. (2007) — 1,280 citations
• E2F1-regulated microRNAs impair TGFbeta-dependent cell-cycle arrest and apoptosis in gastric cancer. (2008) — 902 citations
• Reprogramming of miRNA networks in cancer and leukemia. (2010) — 369 citations
• MicroRNA expression profiles associated with prognosis and therapeutic outcome in colon adenocarcinoma. (2008) — 1,665 citations
• MiR-15a and miR-16-1 cluster functions in human leukemia (2008) — 818 citations
• MicroRNA signatures associated with cytogenetics and prognosis in acute myeloid leukemia. (2008) — 681 citations
• Genomic profiling of microRNA and mRNA reveals deregulated microRNA expression in prostate cancer (2008) — 705 citations
• Cyclin G1 is a target of miR-122a, a microRNA frequently down-regulated in human hepatocellular carcinoma. (2007) — 842 citations
• Relation between microRNA expression and progression and prognosis of gastric cancer: a microRNA expression analysis (2009) — 850 citations
• MicroRNA expression patterns to differentiate pancreatic adenocarcinoma from normal pancreas and chronic pancreatitis. (2007) — 1,185 citations
• MicroRNA expression abnormalities in pancreatic endocrine and acinar tumors are associated with distinctive pathologic features and clinical behavior. (2006) — 797 citations